Abstract
Extracorporeal membrane oxygenation (ECMO) was developed for adults but has been used in neonates as a life-saving rescue therapy for infants with respiratory failure and/or cardiac collapse as a result of congenital diaphragmatic hernia, meconium aspiration syndrome, persistent pulmonary hypertension, or systemic sepsis. ECMO has been proven to increase the survival rate for these diseases. This article provides an overview of neonatal ECMO: the history and development of neonatal ECMO, patient selection criteria, clinical management, the ECMO circuit, weaning from ECMO, and possible complications of ECMO.
| Original language | English |
|---|---|
| Pages (from-to) | 183-188 |
| Number of pages | 6 |
| Journal | Neonatal network : NN |
| Volume | 34 |
| Issue number | 3 |
| DOIs | |
| State | Published - 2015 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pediatrics, Perinatology, and Child Health
- Critical Care and Intensive Care Medicine
- Critical Care
Cite this
Extracorporeal membrane oxygenation in the NICU. / Prine, Kelli Beckvermit; Goracke, Kimberly; Rubarth, Lori Baas.
In: Neonatal network : NN, Vol. 34, No. 3, 2015, p. 183-188.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Extracorporeal membrane oxygenation in the NICU
AU - Prine, Kelli Beckvermit
AU - Goracke, Kimberly
AU - Rubarth, Lori Baas
PY - 2015
Y1 - 2015
N2 - Extracorporeal membrane oxygenation (ECMO) was developed for adults but has been used in neonates as a life-saving rescue therapy for infants with respiratory failure and/or cardiac collapse as a result of congenital diaphragmatic hernia, meconium aspiration syndrome, persistent pulmonary hypertension, or systemic sepsis. ECMO has been proven to increase the survival rate for these diseases. This article provides an overview of neonatal ECMO: the history and development of neonatal ECMO, patient selection criteria, clinical management, the ECMO circuit, weaning from ECMO, and possible complications of ECMO.
AB - Extracorporeal membrane oxygenation (ECMO) was developed for adults but has been used in neonates as a life-saving rescue therapy for infants with respiratory failure and/or cardiac collapse as a result of congenital diaphragmatic hernia, meconium aspiration syndrome, persistent pulmonary hypertension, or systemic sepsis. ECMO has been proven to increase the survival rate for these diseases. This article provides an overview of neonatal ECMO: the history and development of neonatal ECMO, patient selection criteria, clinical management, the ECMO circuit, weaning from ECMO, and possible complications of ECMO.
UR - http://www.scopus.com/inward/record.url?scp=84952647303&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84952647303&partnerID=8YFLogxK
U2 - 10.1891/0730-0832.34.3.183
DO - 10.1891/0730-0832.34.3.183
M3 - Article
C2 - 26802394
AN - SCOPUS:84952647303
VL - 34
SP - 183
EP - 188
JO - Neonatal network : NN
JF - Neonatal network : NN
SN - 0730-0832
IS - 3
ER -